Clinical Trials in Phoenix

Showing 5641-5660 of 16,646 trials

WHOOP ECG Software Performance Assessment Study

NCT06622265

The purpose of the study is to evaluate the performance of ECG classification algorithms and their ability to classify heart rhythms into multiple categories of rhythms and heart rates.

Atrial Fibrillation (AF)

Whoop Inc.540 participantsStarted May 2024

Phoenix, Arizona, United States • Covina, California, United States • Northridge, California, United States +4 more locations

COMPLETED< 1 mile

Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus

NCT00406549

To establish the clinical test performance characteristics of sensitivity, specificity and predictive values for direct detection of nasal Staphylococcus aureus colonization against clinical microbiology laboratory culture methods.

Staphylococcus Aureus

Solventum US LLC2,000 participantsStarted Dec 2006

Phoenix, Arizona, United States • Los Angeles, California, United States • Decatur, Georgia, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

NCT04143594

The primary objective of this study is to evaluate the efficacy of lenacapavir (formerly GS-6207) containing regimens in people living with human immunodeficiency virus (HIV) (PLWH).

HIV-1-infection

Gilead Sciences183 participantsStarted Nov 2019

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +50 more locations

WHOOP ECG Software Performance Assessment Study

Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

Find Trials by Condition in Phoenix

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

The MOTION Study - Treatment of LSS With the MILD Procedure

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults

SMR Stemless Reverse Vs SMR Reverse Shoulder System

Near Patient Molecular Testing in Sepsis

CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension

A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers

Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)